Have a personal or library account? Click to login
Evaluation of Autonomic Nervous System Through Spectral Analysis in Patients with Ischemic Heart Failure: A Systematic Review Cover

Evaluation of Autonomic Nervous System Through Spectral Analysis in Patients with Ischemic Heart Failure: A Systematic Review

Open Access
|Mar 2024

References

  1. S. Guzzetti et al., “Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation,” Circulation, vol. 112, no. 4, pp. 465–470, Jul. 2005, doi: 10.1161/CIRCULATIONAHA.104.518449.
  2. H. V Huikuri, T. Mäkikallio, K. E. Juhani Airaksinen, R. Mitrani, A. Castellanos, and R. J. Myerburg, “Measurement of Heart Rate Variability: A Clinical Tool or a Research Toy?,” J. Am. Coll. Cardiol., vol. 34, pp. 1878–1883, 1999, doi: 10.1016/S0735-1097(99)00468-4.
  3. J. Achten and A. E. Jeukendrup, “Heart rate monitoring: applications and limitations,” Sports Med., vol. 33, no. 7, pp. 517–538, 2003, doi: 10.2165/00007256-200333070-00004.
  4. M. Sadaka, A. Aboelela, S. Arab, and M. Nawar, “Electrocardiogram as prognostic and diagnostic parameter in follow up of patients with heart failure,” Alexandria J. Med., vol. 49, no. 2, pp. 145–152, Jun. 2013, doi: 10.1016/J.AJME.2012.09.002.
  5. D. Moher et al., “Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement,” PLoS Medicine, vol. 6, no. 7. Jul. 2009. doi: 10.1371/journal.pmed.1000097.
  6. B. M. Szabó, D. J. van Veldhuisen, J. Brouwer, J. Haaksma, and K. I. Lie, “Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease,” Am. J. Cardiol., vol. 76, no. 10, pp. 713–716, Oct. 1995, doi: 10.1016/S0002-9149(99)80204-5.
  7. S. Guzzetti et al., “Linear and nonlinear 24 h heart rate variability in chronic heart failure,” Auton. Neurosci., vol. 86, no. 1–2, pp. 114–119, Dec. 2000, doi: 10.1016/S1566-0702(00)00239-3.
  8. V. N. Patel, B. R. Pierce, R. K. Bodapati, D. L. Brown, D. G. Ives, and P. K. Stein, “Association of Holter-Derived Heart Rate Variability Parameters With the Development of Congestive Heart Failure in the Cardiovascular Health Study,” JACC. Heart Fail., vol. 5, no. 6, pp. 423–431, Jun. 2017, doi: 10.1016/J.JCHF.2016.12.015.
  9. M. Galinier et al., “Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure,” Eur. Heart J., vol. 21, no. 6, pp. 475–482, Mar. 2000, doi: 10.1053/EUHJ.1999.1875.
  10. S. Guzzetti et al., “Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure,” Eur. Heart J., vol. 26, no. 4, pp. 357–362, Feb. 2005, doi: 10.1093/EURHEARTJ/EHI067.
  11. P. Ponikowski et al., “Heart rhythms, ventricular arrhythmias, and death in chronic heart failure,” J. Card. Fail., vol. 2, no. 3, pp. 177–183, 1996, doi: 10.1016/S1071-9164(96)80039-X.
  12. C. F. Notarius, J. Spaak, B. L. Morris, and J. S. Floras, “Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure,” J. Card. Fail., vol. 13, no. 6, pp. 470–475, Aug. 2007, doi: 10.1016/J.CARDFAIL.2007.03.014.
  13. A. Voss et al., “Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification,” Front. Physiol., vol. 4, 2013, doi: 10.3389/FPHYS.2013.00364.
  14. J. Sztajzel, “Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system,” Swiss Med. Wkly., vol. 134, no. 35–36, pp. 514–522, Sep. 2004, doi: 10.4414/SMW.2004.10321.
  15. N. Chattipakorn, T. Incharoen, N. Kanlop, and S. Chattipakorn, “Heart rate variability in myocardial infarction and heart failure,” Int. J. Cardiol., vol. 120, no. 3, pp. 289–296, Sep. 2007, doi: 10.1016/J.IJCARD.2006.11.221.
  16. H. V. Huikuri and P. K. Stein, “Heart rate variability in risk stratification of cardiac patients,” Prog. Cardiovasc. Dis., vol. 56, no. 2, pp. 153–159, Sep. 2013, doi: 10.1016/J.PCAD.2013.07.003.
  17. J. J. Atherton et al., “Diastolic ventricular interaction in chronic heart failure: relation to heart rate variability and neurohumoral status,” Heart Vessels, vol. 13, no. 6, pp. 269–277, 1998, doi: 10.1007/BF03257231.
  18. H. A. Malave, A. A. Taylor, J. Nattama, A. Deswal, and D. L. Mann, “Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure,” Chest, vol. 123, no. 3, pp. 716–724, Mar. 2003, doi: 10.1378/CHEST.123.3.716.
  19. M. J. Pearson and N. A. Smart, “Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysis,” Heart Fail. Rev., vol. 23, no. 1, pp. 91–108, Jan. 2018, doi: 10.1007/S10741-017-9662-Z.
  20. F. Besnier et al., “Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial,” Ann. Phys. Rehabil. Med., vol. 62, no. 5, pp. 321–328, Sep. 2019, doi: 10.1016/J.REHAB.2019.06.013.
  21. J. Brouwer et al., “Heart rate variability in patients with mild to moderate heart failure: Effects of neurohormonal modulation by digoxin and ibopamine,” J. Am. Coll. Cardiol., vol. 26, no. 4, pp. 983–990, 1995, doi: 10.1016/0735-1097(95)00285-3.
  22. L. Guedon-Moreau et al., “Effect of ramipril on heart rate variability in digitalis-treated patients with chronic heart failure,” Cardiovasc. Drugs Ther., vol. 11, no. 4, pp. 531–536, 1997, doi: 10.1023/A:1007763131888/METRICS.
  23. F. Pousset et al., “Effects of Bisoprolol on heart rate variability in heart failure,” Am. J. Cardiol., vol. 77, no. 8, pp. 612–617, Mar. 1996, doi: 10.1016/S0002-9149(97)89316-2.
  24. A. Bozkurt, A. Birand, and G. Z. Kudaiberdieva, “Effects of perindopril on autonomic modulation of the heart and left ventricular function: An open-label study,” Curr. Ther. Res., vol. 63, no. 1, pp. 43–51, Jan. 2002, doi: 10.1016/S0011-393X(02)80006-6.
  25. H. Tomiyama et al., “Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure,” Am. Heart J., vol. 137, no. 3, pp. 543–548, Mar. 1999, doi: 10.1016/S0002-8703(99)70504-1.
  26. D. Aronson and A. J. Burger, “Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure,” Ann. Noninvasive Electrocardiol., vol. 6, no. 2, pp. 98–106, 2001, doi: 10.1111/J.1542-474X.2001.TB00093.X.
  27. M. E. Korkmaz, H. Müderrisoglu, M. Uluçam, and B. Özin, “Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure,” Am. J. Cardiol., vol. 86, no. 6, pp. 649–653, Sep. 2000, doi: 10.1016/S0002-9149(00)01046-8.
  28. K. M. Yee, S. D. Pringle, and A. D. Struthers, “Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure,” J. Am. Coll. Cardiol., vol. 37, no. 7, pp. 1800–1807, Jun. 2001, doi: 10.1016/S0735-1097(01)01243-8.
  29. J. I. Davies, M. D. Witham, and A. D. Struthers, “Autonomic effects of spironolactone and MR blockers in heart failure,” Heart Fail. Rev., vol. 10, no. 1, pp. 63–69, Jan. 2005, doi: 10.1007/S10741-005-2350-4.
  30. A. Hamaad, M. Sosin, G. Y. H. Lip, and R. J. MacFadyen, “Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure,” Cardiovasc. drugs Ther., vol. 19, no. 3, pp. 183–187, May 2005, doi: 10.1007/S10557-005-2219-8.
  31. V. Spallone and P. Valensi, “SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement,” Diabetes Metab., vol. 47, no. 4, p. 101224, Jul. 2021, doi: 10.1016/J.DIABET.2021.101224.
  32. A. J. Burger and D. Aronson, “Effect of Diabetes Mellitus on Heart Rate Variability in Patients with Congestive Heart Failure,” Pacing Clin. Electrophysiol., vol. 24, no. 1, pp. 53–59, Jan. 2001, doi: 10.1046/J.1460-9592.2001.00053.X.
  33. A. Mortara and L. Tavazzi, “Prognostic implications of autonomic nervous system analysis in chronic heart failure: Role of heart rate variability and baroreflex sensitivity,” Arch. Gerontol. Geriatr., vol. 23, no. 3, pp. 265–275, Nov. 1996, doi: 10.1016/S0167-4943(96)00727-3.
  34. G. Myers, M. Workman, C. Birkett, D. Ferguson, and M. Kienzle, “Problems in measuring heart rate variability of patients with congestive heart failure,” J. Electrocardiol., vol. 25 Suppl, no. SUPPL., pp. 214–219, 1992, doi: 10.1016/0022-0736(92)90105-9.
  35. G. Q. Wu et al., “Chaotic signatures of heart rate variability and its power spectrum in health, aging and heart failure,” PLoS One, vol. 4, no. 2, Feb. 2009, doi: 10.1371/JOURNAL.PONE.0004323.
DOI: https://doi.org/10.2478/inmed-2024-0275 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 25 - 37
Published on: Mar 29, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Giovanni-Paul Portelli, Iulia-Cristina Stanica, Ana Ciobanu, Ruxandra Dragoi-Galrinho, Ondin Zaharia, Ioan Tiberiu Nanea, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.